Intrathecal trastuzumab for leptomeningeal metastases

11/08/2023 21 min
Intrathecal trastuzumab for leptomeningeal metastases

Listen "Intrathecal trastuzumab for leptomeningeal metastases"

Episode Synopsis

Dr. Iyad Alnahhas interviews Drs. Priya Kumthekar and Jeffrey Raizer about their recent manuscript entitled: A phase I/II study of intrathecal trastuzumab in human epidermal growth factor receptor 2-positive (HER2- positive) cancer with leptomeningeal metastases: Safety, efficacy, and cerebrospinal fluid pharmacokinetics", published online in Neuro-Oncology in March 2023.